Steinhorn B, Eroglu E, Michel T. Chemogenetic Approaches to Probe Redox Pathways: Implications for Cardiovascular Pharmacology and Toxicology. Annu Rev Pharmacol Toxicol. 2022 Jan 6;62:551-571. doi: 10.1146/annurev-pharmtox-012221-082339. Epub 2021 Sep 16. PMID: 34530645. PubMed link
Waldeck-Weiermair M, Yadav S, Spyropoulos F, Krüger C, Pandey AK, Michel T. Dissecting in vivo and in vitro redox responses using chemogenetics. Free Radic Biol Med. 2021 Nov 6:S0891-5849(21)00793-0. doi: 10.1016/j.freeradbiomed.2021.11.006. Epub ahead of print. PMID: 34752919. PubMed link
Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. N Engl J Med. 2020 Apr 23;382(17):1653-1659. doi: 10.1056/NEJMsr2005760. Epub 2020 Mar 30. PMID: 32227760; PMCID: PMC7121452. PubMed link
Lamas S and Michel T. Introduction to redox regulation of cardiovascular signaling. Free Radic Biol Med 2017; 109:1-3.
Kinlay S, Michel T, Leopold J. The future of vascular medicine. Circulation 2016; 133:2603-9.
Michel T. R is for Arginine. Circulation 2013, 128:1400-1404. PubMed link
Maron BA and Michel T. Subcellular localization of oxidants and regulation of endothelial nitric oxide synthase. Circulation Journal 2012, 76 :2497-2512. PMID: 23075817
Michel T. NO way to relax : the complexities of coupling nitric oxide synthase pathways in the heart. Circulation 2010, 121:484-486.
Michel T and Vanhoutte PM. Cellular signaling and NO production. Pflügers Archiv Pharm, 2010, 459:807-816.
Igarashi J and Michel T. Sphingosine 1-phosphate and control of vascular tone. Cardiovascular Research 2009, 82 :212-220.
Michel, T. Nitric oxide synthase 3. UCSD-Nature Molecule Pages 2009 (doi:10.1038/mp.a001660.01).
Igarashi J, Michel T. S1P and eNOS regulation. Biochim Biophys Acta 2008 1781:489-95.
Igarashi J and Michel T. The enigma of sphingosine 1-phosphate synthesis: A novel role for endothelial sphingosine kinases. Circulation Research 2008, 102:630-2.
Lamas, S, Lowenstein CJ and Michel T. Nitric oxide signaling comes of age: 20 years and thriving. Cardiovascular Research 2007, 75:1-3.
Dudzinski D and Michel T. Life history of eNOS: Partners and pathways. Cardiovascular Research 2007, 75:247-60.
Mitchell, DA, Michel T and Marletta M. Effects of S-nitrosation of nitric oxide synthase. Adv Exp Biol 2007, 1:141-179.
Lowenstein, C and Michel T. What’s in a name? eNOS and anaphylactic shock. J Clin Invest, 2006, 116:2075-8.
Dudzinski D, Igarashi J, Greif D and Michel T. Pharmacology and molecular regulation of nitric oxide synthases. Annu Rev Pharmacol Toxicol, 2006, 46:235-76.
Igarashi J and Michel T. More sweetness than light? A search for the causes of diabetic vasculopathy. J Clin Invest 2001; 108:1425-7.
Michel T. Targeting and translocation of endothelial nitric oxide synthase. Braz J Med Biol Res 1999; 32: 1361-6.
Feron O and Michel T. New paradigms in the post-translational regulation of the endothelial isoform of nitric oxide synthase. Nefrologia 1998; 18:90-4.
Michel T and Feron O. Nitric oxide synthases: which, where, why and how? J Clin Invest, 1997, 100: 2146-52.
Sase K and Michel T. Expression and regulation of endothelial nitric oxide synthase. Trends in Cardiovasc Med, 1997; 7:25-34.
Robinson, LJ and Michel T. Expression of endothelial nitric oxide synthase in heterologous cell systems. Methods Enzymol 1996; vol 269, 55-64.
Robinson, LJ, Ghanouni P and Michel, T. Post-translational modifications of endothelial nitric oxide synthase. Methods in Enzymology 1996; 268:436-448.
Smith TW, Balligand JL, Kaye DM, Wiviott SD, Simmons WW, Han X, Michel T, Singh K, Kelly RA. The role of the NO pathway in the control of cardiac function. J Cardiac Failure 1996 4:S141-7.
Michel T and Smith TW. Nitric oxide synthases and cardiovascular signaling. Amer J Cardiol 1993; 72:1C-6C.
Michel T. The guide to politically correct cardiology. J Irreprod Results1993; 38:7-8.
Michel T and Lamas S. Molecular cloning of constitutive endothelial nitric oxide synthase: evidence for a family of related genes. J Cardiovasc Pharmacol 1992; 20:S45-S49.
Lefkowitz RJ, Michel T. Plasma membrane receptors. J Clin Invest 1983; 72:1185-9.
Lefkowitz RJ, Caron MG, Michel T, Stadel JM. Mechanisms of hormone receptor effector coupling: the beta adrenergic receptor and adenylate cyclase. Fed Proc 1982; 41:1664-70.
Lefkowitz RJ, DeLean A, Hoffman BB, Stadel JM, Kent R, Michel T, Limbird L. Molecular pharmacology of adenylate cyclase-coupled alpha and beta adrenergic receptors. Adv Cyclic Nucleotide Res 198; 14:145-61.